@misc
{TN_libero_mab2,
author = {
Spigel, David R.
AND
Edelman, Martin J.
AND
Mok, Tony
AND
O'Byrne, Kenneth John
AND
Paz-Ares, Luis
AND
Yu, Wei
AND
Rittweger, Karen
AND
Thurm, Holger C.
},
title = {
The MetLUNG study: A randomized, double-blind, phase III study of onartuzumab (MetMAb) plus erlotinib versus placebo plus erlotinib in patients with advanced, MET-positive non-small cell lung cancer (NSCLC).
},
publisher = {American Society of Clinical Oncology (ASCO)},
isbn = {0732-183X},
isbn = {1527-7755},
keywords = {
Cancer Research
,
Oncology
},
year = {2012},
url = {
http://slubdd.de/katalog?TN_libero_mab2
}
}